From: Establishment of a yeast-based VLP platform for antigen presentation
Antigen | Primary antibody | Source |
---|---|---|
dS | 7C12a | BioGenes GmbH, Berlin, Germany |
BVDV E2 | WB166 | APHA Scientific, Addlestone, United Kingdom |
CSFV E2 | PrioMab CSFV V8 | Thermo Fisher Scientific, Waltham, USA |
WNV E | Ab00676-23.0 | Absolute Antibody, Oxford, United Kingdom |